Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bacterial Eradication of the Nasal Epithelium From Infectious Toxins With PDT (BENEFIT-PDT)

NCT05090657 is registered in ClinicalTrials.gov with Ondine Biomedical Inc. as lead sponsor.

NCT NCT05090657
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05090657 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bacterial Eradication of the Nasal Epithelium From Infectious Toxins With PDT (BENEFIT-PDT)
Lead sponsor
Ondine Biomedical Inc.
Phase
Phase 2
Overall status
Completed
Start date
February 4, 2022
Completion date
August 6, 2022
Enrollment
322 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthcare associated infections, nosocomial infection, surgical site infections